Ding, Y.; Wang, H.; Liu, J.; Jiang, H.; Gong, A.; Xu, M.
Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185. Cancers 2023, 15, 5120.
https://doi.org/10.3390/cancers15215120
AMA Style
Ding Y, Wang H, Liu J, Jiang H, Gong A, Xu M.
Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185. Cancers. 2023; 15(21):5120.
https://doi.org/10.3390/cancers15215120
Chicago/Turabian Style
Ding, Yuntao, Huizhi Wang, Junqiang Liu, Han Jiang, Aihua Gong, and Min Xu.
2023. "Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185" Cancers 15, no. 21: 5120.
https://doi.org/10.3390/cancers15215120
APA Style
Ding, Y., Wang, H., Liu, J., Jiang, H., Gong, A., & Xu, M.
(2023). Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185. Cancers, 15(21), 5120.
https://doi.org/10.3390/cancers15215120
